Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 4
2004 7
2005 9
2006 12
2007 20
2008 18
2009 7
2010 15
2011 24
2012 21
2013 18
2014 33
2015 33
2016 34
2017 58
2018 45
2019 34
2020 37
2021 42
2022 40
2023 25
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

463 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial.
Yabe D, Nakamura J, Kaneto H, Deenadayalan S, Navarria A, Gislum M, Inagaki N; PIONEER 10 Investigators. Yabe D, et al. Among authors: inagaki n. Lancet Diabetes Endocrinol. 2020 May;8(5):392-406. doi: 10.1016/S2213-8587(20)30074-7. Lancet Diabetes Endocrinol. 2020. PMID: 32333876 Clinical Trial.
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group. Ueki K, et al. Lancet Diabetes Endocrinol. 2017 Dec;5(12):951-964. doi: 10.1016/S2213-8587(17)30327-3. Epub 2017 Oct 24. Lancet Diabetes Endocrinol. 2017. PMID: 29079252 Clinical Trial.
Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding.
Adriaenssens A, Broichhagen J, de Bray A, Ast J, Hasib A, Jones B, Tomas A, Burgos NF, Woodward O, Lewis J, O'Flaherty E, El K, Cui C, Harada N, Inagaki N, Campbell J, Brierley D, Hodson DJ, Samms R, Gribble F, Reimann F. Adriaenssens A, et al. Among authors: inagaki n. JCI Insight. 2023 May 22;8(10):e164921. doi: 10.1172/jci.insight.164921. JCI Insight. 2023. PMID: 37212283 Free PMC article.
[Pancreatic polypeptide].
Fukuda K, Inagaki N, Seino Y. Fukuda K, et al. Among authors: inagaki n. Nihon Rinsho. 2005 Aug;63 Suppl 8:521-3. Nihon Rinsho. 2005. PMID: 16149567 Review. Japanese. No abstract available.
iPSC technology-based regenerative therapy for diabetes.
Kondo Y, Toyoda T, Inagaki N, Osafune K. Kondo Y, et al. Among authors: inagaki n. J Diabetes Investig. 2018 Mar;9(2):234-243. doi: 10.1111/jdi.12702. Epub 2017 Jul 29. J Diabetes Investig. 2018. PMID: 28609558 Free PMC article. Review.
A hyperaldosteronism subtypes predictive model using ensemble learning.
Karashima S, Kawakami M, Nambo H, Kometani M, Kurihara I, Ichijo T, Katabami T, Tsuiki M, Wada N, Oki K, Ogawa Y, Okamoto R, Tamura K, Inagaki N, Yoshimoto T, Kobayashi H, Kakutani M, Fujita M, Izawa S, Suwa T, Kamemura K, Yamada M, Tanabe A, Naruse M, Yoneda T; JPAS/JRAS Study Group. Karashima S, et al. Among authors: inagaki n. Sci Rep. 2023 Feb 21;13(1):3043. doi: 10.1038/s41598-023-29653-2. Sci Rep. 2023. PMID: 36810868 Free PMC article.
463 results